Literature DB >> 12743770

Chronic pancreatitis in Japan: epidemiology, prognosis, diagnostic criteria, and future problems.

Makoto Otsuki1.   

Abstract

Chronic pancreatitis is a chronic clinical disorder characterized by irreversible damage to the pancreas and the development of histologic evidence of inflammation and fibrosis, and eventually the destruction and permanent loss of exocrine and endocrine tissue. A nationwide survey in Japan revealed an increase in the total number of patients treated for chronic pancreatitis from 32 000 in 1994 to 42 000 in 1999. The overall prevalence and the incidence rate of chronic pancreatitis also increased, from 28.5 and 5.4, respectively, in 1994 to 32.91 and 5.77 per 100 000 population, respectively, in 1999. Diagnostic criteria for chronic pancreatitis in Japan were proposed by the Japan Pancreas Society in 1995 and revised in 2001. The criteria were established to rule out false-positive cases and to confidently diagnose definite and probable cases of chronic pancreatitis, and thus easily detect advanced chronic pancreatitis, but the criteria are unable to lead to the early diagnosis of chronic pancreatitis. Cancer is the major cause of death in patients with chronic pancreatitis in Japan (49.6% of all deaths in patients with chronic pancreatitis). Clarification of the mechanisms by which possible chronic pancreatitis progresses to probable or definite chronic pancreatitis, and to pancreatic cancer, is an important research goal. Because even chronic pancreatitis defined as irreversible appears to be reversible for some time in its clinical course, there is an urgent need to develop methods for diagnosing reversible chronic pancreatitis, and to prevent the transition from chronic pancreatitis to pancreatic cancer.

Entities:  

Mesh:

Year:  2003        PMID: 12743770     DOI: 10.1007/s005350300058

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  35 in total

1.  Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer.

Authors:  Jing-Ting Jiang; Chang-Ping Wu; Hai-Feng Deng; Ming-Yang Lu; Jun Wu; Hong-Yu Zhang; Wen-Hui Sun; Mei Ji
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

2.  Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice.

Authors:  Altaf Mohammed; Li Qian; Naveena B Janakiram; Stan Lightfoot; Vernon E Steele; Chinthalapally V Rao
Journal:  Int J Cancer       Date:  2012-03-14       Impact factor: 7.396

3.  Anti-Inflammatory Agents for Cancer Therapy.

Authors:  Elizabeth R Rayburn; Scharri J Ezell; Ruiwen Zhang
Journal:  Mol Cell Pharmacol       Date:  2009

Review 4.  Symposium 3. Chronic pancreatitis: current problems of the diagnostic criteria.

Authors:  Makoto Otsuki
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

Review 5.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 6.  Epidemiology of chronic pancreatitis: burden of the disease and consequences.

Authors:  Philippe Lévy; Enrique Domínguez-Muñoz; Clem Imrie; Matthias Löhr; Patrick Maisonneuve
Journal:  United European Gastroenterol J       Date:  2014-10       Impact factor: 4.623

Review 7.  Role of pancreatic fat in the outcomes of pancreatitis.

Authors:  Chathur Acharya; Sarah Navina; Vijay P Singh
Journal:  Pancreatology       Date:  2014-07-01       Impact factor: 3.996

8.  Demographic and clinicopathological profile of patients with chronic pancreatitis in a tertiary referral teaching hospital of West Bengal: Personal experience.

Authors:  Prosanta Kumar Bhattacharjee; Aishik Mukerjee; Chandranath Adhikary
Journal:  Indian J Gastroenterol       Date:  2015-11-16

9.  Decreased production of immunoglobulin M and A in autoimmune pancreatitis.

Authors:  Masashi Taguchi; Yasuyuki Kihara; Yoshikuni Nagashio; Mitsuyoshi Yamamoto; Makoto Otsuki; Masaru Harada
Journal:  J Gastroenterol       Date:  2009-07-22       Impact factor: 7.527

Review 10.  Alcoholic pancreatitis: pathogenesis, incidence and treatment with special reference to the associated pain.

Authors:  Raffaele Pezzilli; Antonio M Morselli-Labate
Journal:  Int J Environ Res Public Health       Date:  2009-11-04       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.